ADT-OH exhibits anti-metastatic activity on triple-negative breast cancer by combinatorial targeting of autophagy and mitochondrial fission Shihui Yu , Zhiting Cao & Zi-Chun Hua Article 27 June 2024 | Open Access The adhesion-GPCR ADGRF5 fuels breast cancer progression by suppressing the MM...
2. Chen Z, et al. Is HER2 ultra‑low breast cancer different from HER2 null or HER2 low breast cancer? A study of 1363 patients. Breast Cancer Res Treat. 2023 Nov;202(2):313-323. 3. Manohar P, et al. Updates...
5. Yuan P, et al. Eribulin mesilate versus vinorelbine in women with locally recurrent or metastatic breast cancer: A randomised clinical trial. Eur J Cancer. 2019;112:57–65. 6. Jerusalem G, et al. Everolimus Plus Exemestane vs Everolimus or Capecitabine Monotherapy for Estrogen Receptor–Posi...
2. Chen Z, et al. Is HER2 ultra‑low breast cancer different from HER2 null or HER2 low breast cancer? A study of 1363 patients. Breast Cancer Res Treat. 2023 Nov;202(2):313-323. 3. Manohar P, et al. Updates in endocrine therapy for metastatic breast cancer. Cancer Biol Med. 20...
Despite being the hallmark of cancer that is responsible for the highest number of deaths, very little is known about the biology of metastasis. Metastatic disease typically manifests after a protracted period of undetectable disease following surgery or systemic therapy, owing to relapse or recurrence...
Cancer mortality continued to decline through 2021, averting over 4 million deaths since 1991 because of reductions in smoking, earlier detection for some cancers, and improved treatment options in both the adjuvant and metastatic settings. However, these gains are threatened by increasing incidence ...
METASTATIC breast cancerMICROSOFT Corp.CYCLIN-dependent kinase inhibitorsBREAST cancerHORMONE receptor positive breast cancerBackground: MBC is a lethal form of breast cancer that arises when cancer cells invade other organs or tissues. The treatment of MBC needs personalized approaches...
Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115-132. 3. Cardoso F, Spence D, Mertz S, et al. Global analysis of advanced/metastatic breast cancer: Decade report (2005-2015). Breast. 2018;39:131-138. 4. André F, Bachelot T, Commo F, et al. Comparative ...
The breast cancer statistics are only related to the United States. Breast cancer facts: • Breast cancer is one of the leading causes of cancer deaths among women of all races and Hispanic origin populations • One in eight women will develop invasive breast cancer over the course of her...
[8] Nadia Harbeck, Eva Ciruelos, Guy Jerusalem, et al. 2024 SABCS PS14-10: Effects of trastuzumab deruxtecan (T-DXd) on health-related quality of life (HRQOL) & neurological function in patients (pts) w/ HER2+ ...